Senti Biosciences (SNTI) Short Interest Ratio & Short Volume → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free SNTI Stock Alerts $0.40 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Senti Biosciences Short Interest DataCurrent Short Volume165,200 sharesPrevious Short Volume213,800 sharesChange Vs. Previous Month-22.73%Dollar Volume Sold Short$49,758.24Short Interest Ratio / Days to Cover2.0Last Record DateApril 15, 2024Outstanding Shares45,760,000 sharesFloat Size27,380,000 sharesShort Percent of Float0.60%Today's Trading Volume56,911 sharesAverage Trading Volume129,775 sharesToday's Volume Vs. Average44% Short Selling Senti Biosciences ? Sign up to receive the latest short interest report for Senti Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSNTI Short Interest Over TimeSNTI Days to Cover Over TimeSNTI Percentage of Float Shorted Over Time Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… Senti Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024165,200 shares $49,758.24 -22.7%0.6%2 $0.30 3/31/2024213,800 shares $80,623.98 -4.2%0.8%2.1 $0.38 3/15/2024223,200 shares $83,253.60 -17.3%0.8%0.3 $0.37 2/29/2024269,900 shares $116,057.00 -21.9%1.0%0.4 $0.43 2/15/2024345,400 shares $146,795.00 +15.1%1.3%0.5 $0.43 1/31/2024300,000 shares $135,030.00 -30.4%1.2%0.1 $0.45 Get the Latest News and Ratings for SNTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Senti Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024430,700 shares $232,147.30 -44.1%1.6%0.2 $0.54 12/31/2023769,900 shares $508,134.00 +60.8%2.9%0.3 $0.66 12/15/2023478,900 shares $182,987.69 -42.6%1.8%0.2 $0.38 11/30/2023834,000 shares $358,703.40 -44.4%3.2%0.3 $0.43 11/15/20231,500,000 shares $557,700.00 +260.1%5.7%0.6 $0.37 10/31/2023416,500 shares $116,536.70 -8.2%1.6%0.2 $0.28 10/15/2023453,800 shares $137,002.22 +100.6%1.7%1.6 $0.30 9/30/2023226,200 shares $93,420.60 +7.2%0.9%0.9 $0.41 9/15/2023211,000 shares $122,823.10 -32.7%0.8%2.9 $0.58 8/31/2023313,400 shares $203,710.00 -6.8%1.5%4.6 $0.65 8/15/2023336,300 shares $242,472.30 -10.1%1.6%4.8 $0.72 7/31/2023374,200 shares $322,560.40 -12.3%1.9%5.3 $0.86 7/15/2023426,500 shares $298,550.00 +24.9%2.1%4.4 $0.70 6/30/2023341,400 shares $214,057.80 -15.1%1.4%3.5 $0.63 6/15/2023402,300 shares $402,300.00 -12.8%1.6%4.6 $1.00 5/31/2023461,100 shares $407,566.29 -11.0%1.8%5.3 $0.88 5/15/2023517,900 shares $502,363.00 +2.9%2.0%5.8 $0.97 4/30/2023503,500 shares $493,430.00 -0.5%1.9%5.4 $0.98 4/15/2023506,100 shares $541,527.00 +0.2%2.0%4.9 $1.07 3/31/2023505,200 shares $596,136.00 -9.0%2.0%5.3 $1.18 3/15/2023555,200 shares $705,104.00 +12.6%2.2%5.4 $1.27 2/28/2023493,100 shares $739,650.00 -4.4%1.9%2.7 $1.50 2/15/2023515,500 shares $860,885.00 -13.1%2.0%2.8 $1.67 1/31/2023593,300 shares $1.09 million -5.1%1.7%2.8 $1.83 1/15/2023625,100 shares $1.18 million +1.6%1.8%2.4 $1.89 12/30/2022615,500 shares $867,855.00 +65.6%1.8%0.9 $1.41 12/15/2022371,800 shares $565,136.00 -12.3%1.1%0.1 $1.52 11/30/2022423,900 shares $974,970.00 -6.8%1.2%0.1 $2.30 11/15/2022454,700 shares $1.10 million -12.0%1.3%0.1 $2.43 10/31/2022516,900 shares $1.20 million -20.1%1.5%0.1 $2.32 10/15/2022646,600 shares $2.11 million -1.8%1.9%0.1 $3.27 9/30/2022658,400 shares $1.43 million +265.6%1.9%0.1 $2.17 9/15/2022180,100 shares $405,225.00 -23.0%0.5%0.1 $2.25 8/31/2022234,000 shares $458,640.00 -16.1%0.7%0.2 $1.96Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… SNTI Short Interest - Frequently Asked Questions What is Senti Biosciences' current short interest? Short interest is the volume of Senti Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 165,200 shares of SNTI short. 0.60% of Senti Biosciences' shares are currently sold short. Learn More on Senti Biosciences' current short interest. What is a good short interest ratio for Senti Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNTI shares currently have a short interest ratio of 2.0. Learn More on Senti Biosciences's short interest ratio. What is a good short interest percentage for Senti Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.60% of Senti Biosciences' floating shares are currently sold short. Is Senti Biosciences' short interest increasing or decreasing? Senti Biosciences saw a decline in short interest in April. As of April 15th, there was short interest totaling 165,200 shares, a decline of 22.7% from the previous total of 213,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Senti Biosciences' float size? Senti Biosciences currently has issued a total of 45,760,000 shares. Some of Senti Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Senti Biosciences currently has a public float of 27,380,000 shares. How does Senti Biosciences' short interest compare to its competitors? 0.60% of Senti Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Senti Biosciences: PharmaCyte Biotech, Inc. (0.24%), Aptose Biosciences Inc. (0.59%), Evaxion Biotech A/S (0.92%), ZIVO Bioscience, Inc. (4.24%), Coeptis Therapeutics Holdings, Inc. (0.66%), Brainstorm Cell Therapeutics Inc. (2.91%), Genetic Technologies Limited (0.36%), BioCardia, Inc. (1.01%), Organovo Holdings, Inc. (1.49%), Palisade Bio, Inc. (4.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Senti Biosciences stock? Short selling SNTI is an investing strategy that aims to generate trading profit from Senti Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Senti Biosciences? A short squeeze for Senti Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SNTI, which in turn drives the price of the stock up even further. How often is Senti Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNTI, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: PharmaCyte Biotech Short Interest Aptose Biosciences Short Interest Evaxion Biotech A/S Short Interest ZIVO Bioscience Short Interest Coeptis Therapeutics Short Interest Brainstorm Cell Therapeutics Short Interest Genetic Technologies Short Interest BioCardia Short Interest Organovo Short Interest Palisade Bio Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SNTI) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDems have chosen Biden replacement?Paradigm PressThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetryTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange